Education
About Us
Working with TipRanks
Follow Us
Evofem Biosciences (EVFM)
OTHER OTC:EVFM
| Dec 24 | Dec 23 | Mar 23 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 19.36M | $ 18.22M | $ 16.84M | $ 8.24M | $ 446.00K |
| Gross Profit | $ 15.53M | $ 11.71M | $ 12.42M | $ 4.19M | $ -1.20M |
| Operating Income | $ -7.68M | $ -17.85M | $ -84.12M | $ -166.80M | $ -103.62M |
| EBITDA | $ -6.92M | $ -16.07M | $ -82.08M | $ -165.78M | $ -141.12M |
| Net Income | $ -8.86M | $ 52.98M | $ -76.70M | $ -205.19M | $ -142.31M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 741.00K | $ 580.00K | $ 2.77M | $ 7.73M | $ 71.45M |
| Total Assets | $ 23.79M | $ 10.55M | $ 25.16M | $ 42.51M | $ 109.97M |
| Total Debt | $ 45.97M | $ 43.37M | $ 71.13M | $ 115.68M | $ 85.94M |
| Net Debt | $ 45.97M | $ 43.37M | $ 68.36M | $ 107.95M | $ 14.49M |
| Total Liabilities | $ 95.05M | $ 77.06M | $ 96.96M | $ 142.09M | $ 108.62M |
| Stockholders' Equity | $ -71.26M | $ -66.51M | $ -71.80M | $ -99.58M | $ 1.35M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.90M | $ -8.97M | $ -70.75M | $ -149.61M | $ -108.14M |
| Operating Cash Flow | $ -3.88M | $ -8.97M | $ -70.41M | $ -146.67M | $ -105.89M |
| Investing Cash Flow | $ -569.00K | $ -4.00K | $ -341.00K | $ -2.69M | $ 6.23M |
| Financing Cash Flow | $ 4.62M | $ 4.78M | $ 61.94M | $ 90.69M | $ 155.29M |
Evofem Biosciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.